Straumann Holding AG (XSWX:STMN) ROCE %: 4.64% (As of Dec. 2025)


XSWX:STMN Straumann Holding AG XSWX:STMN
99 GF Score
Price CHF106.80
GF Value CHF136.92
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Straumann Holding AG ROCE %?

Straumann Holding AG XSWX:STMN +1.81% 99 ROCE % is 4.64% as of Dec. 2025. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Straumann Holding AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 4.64%.

Straumann Holding AG  (XSWX:STMN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Straumann Holding AG ROCE % Related Terms

Straumann Holding AG ROCE % Historical Data

* Premium members only.

The historical data trend for Straumann Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Straumann Holding AG ROCE % Chart

Straumann Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.62 21.45 22.45 22.00 16.53

Straumann Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.91 31.23 11.96 30.59 4.64
XSWX:STMN
99GF Score
Straumann Holding AG XSWX:STMN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Straumann Holding AG ROCE % Calculation

Straumann Holding AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=470.333/( ( (3618.997 - 943.155) + (3758.162 - 743.609) )/ 2 )
=470.333/( (2675.842+3014.553)/ 2 )
=470.333/2845.1975
=16.53 %

Straumann Holding AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=130.76/( ( (3511.832 - 892.473) + (3758.162 - 743.609) )/ 2 )
=130.76/( ( 2619.359 + 3014.553 )/ 2 )
=130.76/2816.956
=4.64 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.64% mean?
Straumann Holding AG (XSWX:STMN) has a ROCE % of 4.64% as of Dec. 2025.
Is Straumann Holding AG's ROCE % too high?
Straumann Holding AG's current ROCE % is 4.64%. The Medical Devices & Instruments industry median ROCE % is 2.23. Straumann Holding AG's value of 4.64% is 108.1% above this industry median. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's ROCE % compare to ISRG and BDX?
Straumann Holding AG's ROCE % of 4.64% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Straumann Holding AG's value of 4.64% is 108.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current ROCE % of 4.64% is 108.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current ROCE % is 4.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current ROCE % is 4.64% and 108.1% above the Medical Devices & Instruments industry median of 2.23. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current ROCE % is 4.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?

Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued. The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92. GuruFocus considers Straumann Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:STMN:

  • ROCE %: 4.64%
  • GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
  • GF Score™: 99/100 with 7 warning signs
  • Industry Position: 108.1% above the Medical Devices & Instruments median

No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Straumann Holding AG Business Description

Address Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score

Get the complete analysis for XSWX:STMN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF106.80
Price
CHF136.92
GF Value